Open21.620 | Close20.880 |
Vol / Avg.2.041M / 2.323M | Mkt Cap2.430B |
Day Range20.715 - 21.880 | 52 Wk Range3.830 - 21.920 |
CymaBay Therapeutics Stock (NASDAQ: CBAY) stock price, news, charts, stock research, profile.
Open21.620 | Close20.880 |
Vol / Avg.2.041M / 2.323M | Mkt Cap2.430B |
Day Range20.715 - 21.880 | 52 Wk Range3.830 - 21.920 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.300 | -0.320 | -0.0200 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.200 | -0.010 | 0.1900 | ||||
REV | 9.900M | 31.016M | 21.116M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-08 | Cantor Fitzgerald | Kristen Kluska | Maintains | OverweightOverweight | Raises | 23.00 | 24.00 |
2023-11-08 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 21.00 | 24.00 |
2023-11-08 | Raymond James | Steven Seedhouse | Maintains | Strong BuyStrong Buy | Raises | 33.00 | 34.00 |
2023-11-06 | Piper Sandler | Yasmeen Rahimi | Maintains | OverweightOverweight | Raises | 19.00 | 33.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CBAY | CymaBay Therapeutics | -1.56% | 2.4B |
VRNA | Verona Pharma | 6.95% | 1.2B |
SUPN | Supernus Pharmaceuticals | -1.32% | 1.5B |
ANIP | ANI Pharmaceuticals | 0.43% | 999.7M |
NMRA | Neumora Therapeutics | -1.84% | 1.9B |
You can purchase shares of CymaBay Therapeutics (NASDAQ: CBAY) through any online brokerage.
Other companies in CymaBay Therapeutics’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), ANI Pharmaceuticals (NASDAQ:ANIP), Neumora Therapeutics (NASDAQ:NMRA) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for CymaBay Therapeutics (NASDAQ: CBAY) was reported by Cantor Fitzgerald on Wednesday, November 8, 2023. The analyst firm set a price target for 24.00 expecting CBAY to rise to within 12 months (a possible 11.99% upside). 36 analyst firms have reported ratings in the last year.
The stock price for CymaBay Therapeutics (NASDAQ: CBAY) is $21.43 last updated December 8, 2023 at 10:48 PM UTC.
There is no dividend information for CymaBay Therapeutics.
CymaBay Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for CymaBay Therapeutics.
CymaBay Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.